August 7, 2025:
Chai Discovery Secures $70M for AI Drug Models - Chai Discovery secured $70 million in a Series A round led by Menlo Ventures to enhance its AI-driven drug discovery models. Founded in 2024, Chai develops AI models that predict biochemical interactions and design molecules such as antibodies, achieving a 20% success rate compared to the 0.1% of traditional methods.
The funding will be used to improve their platform and expand partnerships, with the goal of accelerating therapeutic medicine development. Chai aims to transform biological research from a trial-and-error process into a precise engineering discipline.
